Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanne Huijberts

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Palliative Medicine|September 18, 2015
End-of-life care during and after an acute hospitalization in older patients with cancer, end-stage organ failure, or frailty: A sub-analysis of a prospective cohort studySanne Huijberts, Bianca M Buurman, Sophia E de Rooij
Future Oncology (London, England)|March 4, 2020
Vorinostat in patients with resistant <i>BRAF</i> mutated advanced melanoma: a proof of concept studySanne Huijberts, Liqin Wang, Rodrigo Leite de Oliveira, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
Cell|May 15, 2018
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic PotentialLiqin Wang, Rodrigo Leite de Oliveira, Sanne Huijberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With <i>BRAF</i> V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer StudyEric Van Cutsem, Sanne Huijberts, Axel Grothey, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Palliative Medicine|September 18, 2015
End-of-life care during and after an acute hospitalization in older patients with cancer, end-stage organ failure, or frailty: A sub-analysis of a prospective cohort studySanne Huijberts, Bianca M Buurman, Sophia E de Rooij
Future Oncology (London, England)|March 4, 2020
Vorinostat in patients with resistant <i>BRAF</i> mutated advanced melanoma: a proof of concept studySanne Huijberts, Liqin Wang, Rodrigo Leite de Oliveira, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
Cell|May 15, 2018
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic PotentialLiqin Wang, Rodrigo Leite de Oliveira, Sanne Huijberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With <i>BRAF</i> V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer StudyEric Van Cutsem, Sanne Huijberts, Axel Grothey, et al.
Pageof 1